Department of Chemistry, Michigan Technological University, Houghton, Michigan 49931, United States.
Department of Chemistry, and Health Research Institute, Michigan Technological University, Houghton, Michigan 49931, United States.
ACS Appl Bio Mater. 2023 Aug 21;6(8):3199-3212. doi: 10.1021/acsabm.3c00320. Epub 2023 Aug 9.
We have developed two highly sensitive cyanine dyes, which we refer to as probes and . These dyes are capable of quick and sensitive sensing of NAD(P)H. The dyes were fabricated by connecting benzothiazolium and 2,3-dimethylnaphtho[1,2-]thiazol-3-ium units to 3-quinolinium through a vinyl bond. In the absence of NAD(P)H, both probes have low fluorescence and absorption peaks at 370 and 400 nm, correspondingly. This is because of their two electron-withdrawing acceptor systems with high charge densities. However, when NAD(P)H reduces the probes' electron-withdrawing 3-quinolinium units to electron-donating 1,4-dihydroquinoline units, the probes absorb at 533 and 535 nm and fluoresce at 572 and 586 nm for and correspondingly. This creates well-defined donor-π-acceptor cyanine dyes. We successfully used probe to monitor NAD(P)H levels in live cells during glycolysis, under hypoxic conditions induced by CoCl treatment and after treatment with cancer drugs, including cisplatin, camptothecin, and gemcitabine. Probe was also employed to visualize NAD(P)H in first-instar larvae. We observed an increase in NAD(P)H levels in A549 cancer cells both under hypoxic conditions and after treatment with cancer drugs, including cisplatin, camptothecin, and gemcitabine.
我们开发了两种高灵敏度的菁染料,我们分别称之为探针和。这些染料能够快速、灵敏地感应 NAD(P)H。染料是通过将苯并噻唑和 2,3-二甲基萘[1,2-]噻唑-3-鎓单元通过乙烯基键连接到 3-喹啉鎓上制成的。在没有 NAD(P)H 的情况下,两种探针的荧光和吸收峰均在 370nm 和 400nm 处,这是因为它们具有两个高电荷密度的吸电子受体系统。然而,当 NAD(P)H 将探针的吸电子 3-喹啉鎓单元还原为给电子 1,4-二氢喹啉单元时,探针在 533nm 和 535nm 处吸收,和探针相应地在 572nm 和 586nm 处发出荧光。这就产生了明确定义的供体-π-受体菁染料。我们成功地使用探针在糖酵解过程中监测活细胞中的 NAD(P)H 水平,在 CoCl 处理诱导的缺氧条件下以及在用包括顺铂、喜树碱和吉西他滨在内的癌症药物处理后监测 NAD(P)H 水平。探针还用于可视化第一龄幼虫中的 NAD(P)H。我们观察到 A549 癌细胞在缺氧条件下和用包括顺铂、喜树碱和吉西他滨在内的癌症药物处理后 NAD(P)H 水平增加。